​

Cardinal Health (CAH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CAH Stock Forecast

Cardinal Health stock forecast is as follows: an average price target of $118.43 (represents a -7.30% downside from CAH’s last price of $127.76) and a rating consensus of 'Buy', based on 17 wall street analysts offering a 1-year stock forecast.

CAH Price Target

The average price target for Cardinal Health (CAH) is $118.43 based on 1-year price targets from 17 Wall Street analysts in the past 3 months, with a price target range of $140.00 to $101.00. This represents a potential -7.30% downside from CAH's last price of $127.76.

CAH Analyst Ratings

Buy

According to 17 Wall Street analysts, Cardinal Health's rating consensus is 'Buy'. The analyst rating breakdown for CAH stock is 0 'Strong Buy' (0.00%), 9 'Buy' (52.94%), 6 'Hold' (35.29%), 2 'Sell' (11.76%), and 0 'Strong Sell' (0.00%).

Cardinal Health Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 23, 2024Eric ColdwellRobert W. Baird$140.00$112.3024.67%9.58%
Sep 11, 2024David ToungArgus Research$125.00$112.3611.25%-2.16%
Aug 16, 2024George HillDeutsche Bank$119.00$107.9110.28%-6.86%
Aug 15, 2024Elizabeth AndersonEvercore ISI$115.00$107.716.77%-9.99%
Aug 15, 2024Erin WrightMorgan Stanley$119.00$106.3611.88%-6.86%
Aug 15, 2024Ann HynesMizuho Securities$110.00$107.392.43%-13.90%
Aug 15, 2024Eric ColdwellRobert W. Baird$137.00$107.3327.64%7.23%
Aug 15, 2024Stephen BaxterWells Fargo$101.00$106.36-5.04%-20.95%
Jun 11, 2024Garrett NelsonCFRA$111.00$99.0112.11%-13.12%
May 29, 2024Eric ColdwellRobert W. Baird$129.00$94.7536.15%0.97%
May 15, 2024David ToungArgus Research$115.00$97.4318.03%-9.99%
May 03, 2024Eric ColdwellRobert W. Baird$128.00$102.9824.30%0.19%
Apr 05, 2024Eric ColdwellRobert W. Baird$134.00$110.1221.69%4.88%
Aug 15, 2023Erin WrightMorgan Stanley$90.00$92.99-3.22%-29.56%
Apr 12, 2023Tim AndersonWolfe Research$127.00$79.1960.38%-0.59%
Feb 08, 2023Baird BairdRobert W. Baird$94.00$78.6119.58%-26.42%
Feb 03, 2023Credit Suisse$92.00$80.1414.80%-27.99%
Jan 06, 2023Morgan Stanley$86.00$78.1210.09%-32.69%
Nov 22, 2022Credit Suisse$79.00$79.22-0.27%-38.17%
Aug 29, 2022UBS$78.00$68.5113.85%-38.95%
May 20, 2022Elizabeth AndersonEvercore ISI$68.00$55.8321.80%-46.78%
May 08, 2022George HillDeutsche Bank$51.00$58.27-12.48%-60.08%
Apr 16, 2022Ricky GoldwasserMorgan Stanley$74.00$62.9617.53%-42.08%
Jan 17, 2022Steve ValiquetteBarclays$63.00$53.0918.67%-50.69%
Nov 17, 2021Kevin CaliendoUBS$61.00$48.8424.90%-52.25%
Aug 11, 2021Charles RhyeeCowen & Co.$53.00$50.285.41%-58.52%
Aug 05, 2021Michael ChernyBank of America Securities$56.00$49.2013.82%-56.17%

The latest Cardinal Health stock forecast, released on Sep 23, 2024 by Eric Coldwell from Robert W. Baird, set a price target of $140.00, which represents a 24.67% increase from the stock price at the time of the forecast ($112.30), and a 9.58% increase from CAH last price ($127.76).

Cardinal Health Price Target by Period

1M3M12M
# Anlaysts--13
Avg Price Target--$121.77
Last Closing Price$127.76$127.76$127.76
Upside/Downside-100.00%-100.00%-4.69%

In the current month, the average price target of Cardinal Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cardinal Health's last price of $127.76. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025CitigroupNeutralNeutralHold
Jan 07, 2025Evercore ISIOutperformOutperformUpgrade
Sep 23, 2024Cowen & Co.HoldHoldHold
Aug 16, 2024Deutsche BankHoldHoldHold
Aug 15, 2024Cowen & Co.HoldHoldHold
Aug 15, 2024Evercore ISIOutperformOutperformHold
Aug 15, 2024Cowen & Co.BuyBuyHold
Aug 15, 2024Morgan StanleyOverweightOverweightHold
Aug 14, 2024Wells FargoUnderweightUnderweightHold
Aug 14, 2024Argus ResearchBuyBuyHold
Aug 14, 2024UBSBuyBuyHold
May 02, 2024Morgan StanleyOverweightOverweightHold
Apr 22, 2024Cowen & Co.HoldHoldHold
Mar 14, 2024RBC CapitalSector PerformDowngrade
Aug 15, 2023UBSBuyBuyHold
Aug 15, 2023Morgan StanleyOverweightOverweightHold
Aug 15, 2023Credit SuisseNeutralNeutralHold
Jul 27, 2023CFRASellUpgrade
Jun 12, 2023UBSBuyBuyHold
Apr 12, 2023Wolfe ResearchOutperformUpgrade
Feb 08, 2023Robert W. BairdOutperformUpgrade
Feb 03, 2023Goldman SachsBuyInitialise
Feb 03, 2023Morgan StanleyOverweightOverweightHold
Jan 06, 2023Morgan StanleyOverweightOverweightHold
Nov 22, 2022Credit SuisseNeutralNeutralHold
Nov 04, 2022Bank of America SecuritiesNeutralUpgrade
Aug 29, 2022UBSBuyBuyHold
Aug 16, 2022Deutsche BankHoldHoldHold
Aug 16, 2022Morgan StanleyOverweightOverweightHold
Aug 12, 2022BenchmarkBuyBuyHold
May 18, 2022Evercore ISIOutperformUpgrade
Apr 15, 2022Morgan StanleyEqual-WeightUpgrade
Jan 17, 2022BarclaysOverweightOverweightHold

Cardinal Health's last stock rating was published by Citigroup on Jan 10, 2025. The company gave CAH a "Neutral" rating, the same as its previous rate.

Cardinal Health Financial Forecast

Cardinal Health Revenue Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
Revenue--------------$57.45B$54.76B$53.45B$50.49B$51.47B$49.60B$47.10B$44.84B$45.46B$44.84B$42.59B$39.06B$41.54B$39.27B$36.69B$37.34B
Avg Forecast$70.33B$64.05B$66.05B$65.40B$63.19B$58.16B$59.54B$57.93B$59.34B$54.61B$55.02B$50.90B$58.64B$56.05B$57.02B$54.85B$52.72B$49.71B$50.72B$48.19B$44.89B$43.12B$45.59B$41.84B$40.39B$40.06B$41.41B$38.16B$36.85B$37.00B
High Forecast$71.77B$65.37B$67.41B$66.75B$64.48B$59.35B$60.76B$59.12B$60.56B$55.47B$56.32B$51.94B$58.64B$56.05B$57.50B$55.49B$53.80B$50.73B$51.94B$48.19B$44.89B$43.12B$45.59B$41.84B$40.39B$40.06B$41.41B$38.16B$36.85B$37.00B
Low Forecast$68.55B$62.44B$64.38B$63.75B$61.59B$56.69B$58.04B$56.47B$57.84B$52.89B$53.68B$49.61B$58.64B$56.05B$56.80B$53.90B$51.39B$48.45B$48.63B$48.19B$44.89B$43.12B$45.59B$41.84B$40.39B$40.06B$41.41B$38.16B$36.85B$37.00B
# Analysts476446437994445854434354545999
Surprise %--------------1.01%1.00%1.01%1.02%1.01%1.03%1.05%1.04%1.00%1.07%1.05%0.98%1.00%1.03%1.00%1.01%

Cardinal Health's average Quarter revenue forecast for Mar 24 based on 4 analysts is $56.05B, with a low forecast of $56.05B, and a high forecast of $56.05B. CAH's average Quarter revenue forecast represents a -2.42% decrease compared to the company's last Quarter revenue of $57.45B (Dec 23).

Cardinal Health EBITDA Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
# Analysts476446437994445854434354545999
EBITDA--------------$691.00M$-14.00M$666.00M$707.00M$578.00M$515.00M$512.00M$644.00M$563.00M$644.00M$436.00M$654.00M$724.00M$792.00M$585.00M$660.00M
Avg Forecast$104.00M$94.72M$97.67M$96.71M$93.44M$86.00M$88.05M$85.67M$87.75M$80.76M$81.36M$75.26M$86.71M$103.13M$84.31M$81.11M$77.96M$93.76M$-821.58M$686.83M$639.88M$85.24M$649.90M$596.43M$575.72M$691.81M$590.29M$543.97M$525.28M$659.89M
High Forecast$106.14M$96.67M$99.68M$98.70M$95.36M$87.77M$89.86M$87.43M$89.55M$82.03M$83.29M$76.81M$86.71M$123.76M$85.03M$82.06M$79.56M$112.51M$-657.27M$686.83M$639.88M$102.28M$649.90M$596.43M$575.72M$830.18M$590.29M$543.97M$525.28M$791.87M
Low Forecast$101.37M$92.33M$95.20M$94.27M$91.08M$83.83M$85.82M$83.51M$85.53M$78.20M$79.38M$73.36M$86.71M$82.51M$83.99M$79.71M$75.99M$75.01M$-985.90M$686.83M$639.88M$68.19M$649.90M$596.43M$575.72M$553.45M$590.29M$543.97M$525.28M$527.91M
Surprise %--------------8.20%-0.17%8.54%7.54%-0.70%0.75%0.80%7.56%0.87%1.08%0.76%0.95%1.23%1.46%1.11%1.00%

4 analysts predict CAH's average Quarter EBITDA for Mar 24 to be $103.13M, with a high of $123.76M and a low of $82.51M. This is -85.07% lower than Cardinal Health's previous annual EBITDA (Dec 23) of $691.00M.

Cardinal Health Net Income Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
# Analysts476446437994445854434354545999
Net Income--------------$353.00M$5.00M$-64.00M$345.00M$-130.00M$110.00M$138.00M$-1.39B$49.00M$-1.39B$116.00M$119.00M$629.00M$120.00M$656.00M$350.00M
Avg Forecast$610.45M$677.45M$560.14M$581.09M$540.73M$588.83M$489.90M$505.93M$493.68M$539.51M$433.01M$396.63M$424.81M$-1.77B$391.36M$343.96M$365.95M$-1.61B$52.15M$229.61M$289.78M$-1.46B$301.65M$323.45M$293.55M$120.54M$353.45M$277.69M$220.42M$303.50M
High Forecast$626.75M$695.55M$575.11M$596.62M$555.17M$604.56M$502.99M$519.45M$506.87M$559.59M$460.38M$406.11M$424.82M$-1.42B$411.43M$366.07M$375.72M$-1.29B$62.58M$229.61M$293.22M$-1.17B$301.65M$332.63M$293.55M$144.64M$353.45M$277.69M$220.42M$364.20M
Low Forecast$590.41M$655.22M$541.76M$562.02M$522.98M$569.50M$473.82M$489.32M$477.47M$526.97M$363.33M$387.14M$424.80M$-2.13B$376.30M$329.22M$353.93M$-1.93B$41.72M$229.61M$286.33M$-1.76B$301.65M$314.28M$293.55M$96.43M$353.45M$277.69M$220.42M$242.80M
Surprise %--------------0.90%0.01%-0.17%-0.21%-2.49%0.48%0.48%0.95%0.16%-4.30%0.40%0.99%1.78%0.43%2.98%1.15%

Cardinal Health's average Quarter net income forecast for Mar 24 is $-1.77B, with a range of $-2.13B to $-1.42B. CAH's average Quarter net income forecast represents a -601.73% decrease compared to the company's last Quarter net income of $353.00M (Dec 23).

Cardinal Health SG&A Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
# Analysts476446437994445854434354545999
SG&A--------------$1.28B$1.20B$1.27B$1.18B$1.19B$1.20B$1.16B$1.14B$1.15B$1.14B$1.13B$1.14B$1.15B$1.12B$1.14B$1.11B
Avg Forecast$1.81B$1.65B$1.70B$1.68B$1.62B$1.50B$1.53B$1.49B$1.53B$1.40B$1.41B$1.31B$1.51B$1.45B$1.47B$1.41B$1.36B$1.32B$1.22B$1.24B$1.15B$1.20B$1.17B$1.08B$1.04B$1.13B$1.06B$981.16M$947.45M$1.01B
High Forecast$1.85B$1.68B$1.73B$1.72B$1.66B$1.53B$1.56B$1.52B$1.56B$1.43B$1.45B$1.34B$1.51B$1.74B$1.48B$1.43B$1.38B$1.58B$1.47B$1.24B$1.15B$1.44B$1.17B$1.08B$1.04B$1.36B$1.06B$981.16M$947.45M$1.21B
Low Forecast$1.76B$1.61B$1.66B$1.64B$1.58B$1.46B$1.49B$1.45B$1.49B$1.36B$1.38B$1.28B$1.51B$1.16B$1.46B$1.39B$1.32B$1.05B$979.94M$1.24B$1.15B$957.16M$1.17B$1.08B$1.04B$907.56M$1.06B$981.16M$947.45M$808.17M
Surprise %--------------0.88%0.85%0.93%0.90%0.97%0.97%1.00%0.95%0.98%1.06%1.09%1.00%1.08%1.14%1.20%1.10%

Cardinal Health's average Quarter SG&A projection for Mar 24 is $1.45B, based on 4 Wall Street analysts, with a range of $1.16B to $1.74B. The forecast indicates a 12.84% rise compared to CAH last annual SG&A of $1.28B (Dec 23).

Cardinal Health EPS Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
# Analysts476446437994445854434354545999
EPS--------------$1.44$0.02$-0.25$1.35$-0.50$0.41$0.51$-5.05$0.18$-5.05$0.40$-0.86$2.14$0.41$2.25$-16.62
Avg Forecast$2.49$2.77$2.29$2.37$2.21$2.40$2.00$2.07$2.02$2.20$1.77$1.62$1.73$1.95$1.60$1.40$1.49$1.49$1.14$0.94$1.18$1.52$1.23$1.32$1.20$1.55$1.44$1.13$0.90$1.43
High Forecast$2.56$2.84$2.35$2.44$2.27$2.47$2.05$2.12$2.07$2.28$1.88$1.66$1.73$1.95$1.68$1.49$1.53$1.52$1.18$0.94$1.20$1.57$1.23$1.36$1.20$1.55$1.44$1.13$0.90$1.43
Low Forecast$2.41$2.67$2.21$2.29$2.13$2.32$1.93$2.00$1.95$2.15$1.48$1.58$1.73$1.95$1.54$1.34$1.44$1.46$1.08$0.94$1.17$1.48$1.23$1.28$1.20$1.55$1.44$1.13$0.90$1.43
Surprise %--------------0.90%0.01%-0.17%0.91%-0.44%0.44%0.43%-3.31%0.15%-3.83%0.33%-0.55%1.48%0.36%2.50%-11.60%

According to 4 Wall Street analysts, Cardinal Health's projected average Quarter EPS for Mar 24 is $1.95, with a low estimate of $1.95 and a high estimate of $1.95. This represents a 35.65% increase compared to CAH previous annual EPS of $1.44 (Dec 23).

Cardinal Health Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
EDAPEDAP TMS$2.28$19.00733.33%Buy
ZYXIZynex$8.27$11.7542.08%Buy
MCKMcKesson$603.18$626.713.90%Buy
OMIOwens & Minor$14.92$14.00-6.17%Buy
CAHCardinal Health$127.76$118.43-7.30%Buy
HSICHenry Schein$79.87$70.50-11.73%Buy
PDCOPatterson Companies$30.95$23.00-25.69%Buy

CAH Forecast FAQ

Is Cardinal Health a good buy?

Yes, according to 17 Wall Street analysts, Cardinal Health (CAH) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 52.94% of CAH's total ratings.

What is CAH's price target?

Cardinal Health (CAH) average price target is $118.43 with a range of $101 to $140, implying a -7.30% from its last price of $127.76. The data is based on 17 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Cardinal Health stock go up soon?

According to Wall Street analysts' prediction for CAH stock, the company can go down by -7.30% (from the last price of $127.76 to the average price target of $118.43), up by 9.58% based on the highest stock price target, and down by -20.95% based on the lowest stock price target.

Can Cardinal Health stock reach $200?

CAH's average twelve months analyst stock price target of $118.43 does not support the claim that Cardinal Health can reach $200 in the near future.

What are Cardinal Health's analysts' financial forecasts?

Cardinal Health's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $238.82B (high $243.73B, low $232.79B), average EBITDA is $353.15M (high $360.41M, low $344.24M), average net income is $2.13B (high $2.18B, low $2.06B), average SG&A $6.14B (high $6.27B, low $5.98B), and average EPS is $8.68 (high $8.91, low $8.39). CAH's analysts financial forecasts for the fiscal year (Jun 2027) are as follows: average revenue is $265.83B (high $271.3B, low $259.12B), average EBITDA is $393.1M (high $401.18M, low $383.18M), average net income is $2.43B (high $2.49B, low $2.35B), average SG&A $6.83B (high $6.97B, low $6.66B), and average EPS is $9.91 (high $10.18, low $9.59).

Did the CAH's actual financial results beat the analysts' financial forecasts?

Based on Cardinal Health's last annual report (Jun 2023), the company's revenue was $205.01B, beating the average analysts forecast of $201.34B by 1.83%. Apple's EBITDA was $2.47B, beating the average prediction of $36.97M by 6570.70%. The company's net income was $261M, missing the average estimation of $-962M by -127.12%. Apple's SG&A was $4.83B, missing the average forecast of $5.14B by -5.87%. Lastly, the company's EPS was $1, missing the average prediction of $5.06 by -80.23%. In terms of the last quarterly report (Dec 2023), Cardinal Health's revenue was $57.44B, beating the average analysts' forecast of $57.02B by 0.75%. The company's EBITDA was $691M, beating the average prediction of $84.31M by 719.56%. Cardinal Health's net income was $353M, missing the average estimation of $391.36M by -9.80%. The company's SG&A was $1.28B, missing the average forecast of $1.47B by -12.47%. Lastly, the company's EPS was $1.44, missing the average prediction of $1.6 by -9.85%